This opportunity is no longer accepting applications.
contract ARPA-H-SOL-25-122
Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
Dates
Response Deadline: December 20, 2025
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers